“十五五”动物重大疫病综合防控科技创新建议

doi:10.11924/j.issn.1000-6850.casb2025-0785

摘要/Abstract

摘要：

针对中国畜牧业在“十五五”期间面临的重大动物疫病、人兽共患病、寄生虫病及细菌耐药性等多重挑战，为保障产业与公共卫生安全，本建议提出一套系统性的动物疫病综合防控科技创新战略。在分析中国动物疫病防控现状与瓶颈的基础上，聚焦病原致病机制、人兽共患病防控、寄生虫病防治、细菌耐药性控制及新兽药创制五大领域，规划了关键研究路径与目标，绘制了“十五五”科技攻关蓝图。该蓝图强调以基础研究为支撑，深入解析病原致病与免疫逃逸机制；以关键技术为突破口，重点布局新型疫苗、新兽药及智能化监测诊断体系的研发；并针对寄生虫病和细菌耐药性问题制定专项防控策略。实施本建议有望突破核心技术瓶颈，提升中国动物重大疫病综合防控能力，对保障养殖业可持续发展与公共卫生安全具有重大战略意义，为“十五五”动物防疫工作提供顶层设计指导。

关键词: 动物疫病, 科技创新, 人兽共患病, 新兽药, 十五五规划

Abstract:

In response to multiple challenges facing China's animal husbandry industry, including major animal diseases, zoonotic diseases, parasitic diseases, and bacterial resistance, the proposal of this study aims to establish a systematic scientific and technological innovation strategy for the comprehensive prevention and control of animal diseases during the '15^th Five-Year Plan' period, thereby safeguarding industrial and public health security. By analyzing the current situation and bottlenecks in animal disease prevention and control in China, the study focuses on five key areas: pathogenic mechanisms, zoonotic diseases, parasitic diseases, bacterial resistance, and the development of new veterinary drugs, outlining core research pathways and objectives. A blueprint for scientific and technological during the '15^th Five-Year Plan' period is proposed. Basic research focuses on pathogenic mechanisms and immune evasion strategies, while key technological initiatives include the development of novel vaccines, new veterinary drugs, and intelligent monitoring and diagnostic systems. Specific strategies are also outlined for addressing parasitic diseases and bacterial resistance. The implementation of this proposal is expected to achieve breakthroughs in core technologies, enhance China's comprehensive capacity for major animal disease prevention and control, and hold significant strategic importance for ensuring the development of the breeding industry and public health security. It provides a top-level design for animal disease prevention efforts during the '15^th Five-Year Plan' period.

Key words: animal diseases, scientific and technological innovation, zoonotic diseases, new veterinary drugs, 15^th Five-Year Plan

冯耀宇, 廖晓萍, 肖立华, 陈金顶, 陈建新, 李守军, 任涛, 张桂红, 郭世宁, 黄耀伟, 张建民, 孙坚. “十五五”动物重大疫病综合防控科技创新建议[J]. 中国农学通报, 2025, 41(26): 52-62.

FENG Yaoyu, LIAO Xiaoping, XIAO Lihua, CHEN Jinding, CHEN Jianxin, LI Shoujun, REN Tao, ZHANG Guihong, GUO Shining, HUANG Yaowei, ZHANG Jianmin, SUN Jian. Science and Technology Innovation Suggestions for Comprehensive Prevention and Control of Major Animal Diseases During 15^th Five-Year Plan Period[J]. Chinese Agricultural Science Bulletin, 2025, 41(26): 52-62.

参考文献 38

[1]	石自忠, 胡向东. 加快建设畜牧强国的理论逻辑与战略路径[J]. 中国农业科技导报, 2023, 25(9):1-12.
[2]	鄢朝晖. 科技投入、技术创新对畜牧业高质量发展的影响研究[D]. 北京: 中国农业科学院, 2024.
[3]	靳晓明, 于志宇, 丁洪双, 等. 对动物重大疫病综合防控的思考与建议[J]. 疫病防控, 2025(7):87-91
[4]	刘青芸, 邬沛伶, 王湘如, 等. 新形势下我国人兽共患病防控挑战与应对策略[J]. 中国工程科学, 2024, 26(5):199-211. doi: 10.15302/J-SSCAE-2024.05.019
[5]	陈怡. 从源头前端阻断人兽共患病的传播路径[N]. 上海科技报,2025-3-21(1).
[6]	秦思源, 孙贺廷, 耿海东, 等. 野生动物与外来人兽共患病[J]. 野生动物学报, 2019, 40(1):204-208.
[7]	王旭, 尹建海, 韩帅, 等. 寄生虫的健康威胁与生态功能[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(4):1-6.
[8]	马凯琪, 贾淑侠, 李才善. 我国动物源细菌耐药性的现状研究[J]. 今日畜牧兽医, 2024(7):61-64.
[9]	高铎, 李欣南, 韩镌竹, 等. 动物源细菌耐药性的形成、影响、现状及建议[J]. 饲料博览, 2021(12):7-18.
[10]	董路, 关少君, 段博芳, 等. 包虫病的流行与诊治研究进展[J]. 草学, 2024(2):70-76.
[11]	王辉, 曹珂瑶, 李雨霏, 等. 猪场弓形虫病风险因素、综合防控与净化[J]. 中国农业大学学报, 2025, 30(9):149-160.
[12]	冯伉梨. 牛隐孢子虫和芮氏隐孢子虫在奶牛中的感染动态研究[D]. 广州: 华南农业大学, 2024.
[13]	辛连喜, 瓦热斯·吐尔松, 艾力西热·买买提, 等. 捻转血矛线虫伊维菌素抗药性相关miRNA鉴定及其功能分析[J]. 畜牧与兽医, 2025, 57(9):93-103.
[14]	杨小迪, 徐常艳, 王舒颖, 等. 我国旋毛虫病流行病学诊断治疗及防治措施研究进展[J]. 中国血吸虫病防治杂志, 2020, 32(5):448-452.
[15]	龚凤君. 巴贝斯虫的传播阻断疫苗候选分子筛选及鉴定[D]. 北京: 中国农业科学院, 2024.
[16]	刘勇, 蒋彤, 葛婉淇, 等. 东北地区重要蜱虫种类与蜱传疾病研究进展[J]. 中华卫生杀虫药械, 2023, 29(2):176-179.
[17]	遏制微生物耐药国家行动计划(2022—2025年)[J]. 中国感染控制杂志, 2022, 21(12):1264-1266.
[18]	TAKAFUMI S, KENJI Y. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin[J]. Clinical infectious diseases: an official publication of the infectious diseases Society of America, 2019, 69(S7):S538-S543.
[19]	郐俊扬, 王晓娟, 王辉. 头孢地尔:新型铁载体头孢菌素抗多重耐药革兰阴性杆菌感染[J]. 生物工程学报, 2022, 38(3):990-1003.
[20]	JOSEPH J, BOBY S, MOOYOTTU S, et al. Antibiotic potentiators as a promising strategy for combating antibiotic resistance[J]. npj Antimicrobials and resistance, 2025, 3(1):53.
[21]	COSTANZO V, ROVIELLO G N. The Potential role of vaccines in preventing antimicrobial resistance (AMR): an update and future perspectives[J]. Vaccines, 2023, 11(2):333.
[22]	罗曼, 万婧倞, 黄仕新, 等. 南极沉积物来源抗菌细菌的筛选及抑菌物质的鉴定[J]. 微生物学通报, 2020, 47(6):1787-1794.
[23]	马磊, 杨昭庆, 王佑春. 全球疫苗研发现状和展望[J]. 中国药科大学学报, 2024, 55(1):115-126.
[24]	徐寅生, 任翔宇, 余梦真, 等. 基于纳米技术的药物递送策略及其在癌症治疗中的应用[J]. 科学通报, 2023, 68(32):4346-4372.
[25]	张琳宇, 董春艳, 谭德讲, 等. CpG ODN佐剂的最新研究进展与挑战[J]. 中国生物制品学杂志, 2025, 38(6):746-752.
[26]	李超, 刘红旗. 亚单位疫苗研究进展[C]. 中国免疫学会(Chinese Society for Immunology).第十届全国免疫学学术大会汇编.中国医学科学院医学生物学研究所感染和免疫实验室, 2015.
[27]	樊渝川, 殷涵, 李钰, 等. mRNA疫苗与脂质纳米颗粒递送载体的研究进展[J]. 科学通报, 2024, 69(33):4813-4823.
[28]	陈艺兰. 基于猪圆环病毒2型病毒样颗粒的通用型纳米抗原展示平台的构建及其免疫应答研究[D]. 杨凌: 西北农林科技大学, 2023.
[29]	刘元杰, 张媛, 王秀丽, 等. 新型动物疫苗佐剂的研究进展[J]. 中国兽药杂志, 2021, 55(2):74-80.
[30]	李侠, 王群义. 我国防控高致病性禽流感应考虑的因素[J]. 中国兽医杂志, 2015, 51(11):109-110.
[31]	MOROSINI M I, CANTÓN R, LOZA E, et al. In Vitro activity of telithromycin against Spanish streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms[J]. Antimicrob agents chemother, 2001, 45(9):2427-2431.
[32]	POULSEN S M, KARLSSON M, JOHANSSON L B, et al. The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome[J]. Molecular microbiology, 2001, 41(5):1091-1099. pmid: 11555289
[33]	NUNES A R, ALVES G, FALCÃO A, et al. Phenolic acids from fruit by-products as therapeutic agents for metabolic syndrome: A review[J]. International journal of mechanical sciences, 2025, 26 (8):3834.
[34]	KUMAR N, GOEL N. Phenolic acids: natural versatile molecules with promising therapeutic applications[J]. Biotechnology reports, 2019,24e00370.
[35]	MACE S, TRUELSTRUP-HANSEN L, RUPASINGHE V P H. Anti-Bacterial activity of phenolic compounds against streptococcus pyogenes[J]. Medicines, 2017, 4(2):25-25.
[36]	KEASLING D J. Manufacturing molecules through metabolic engineering[J]. Science, 2010, 330(6009):1355-1358. doi: 10.1126/science.1193990 pmid: 21127247
[37]	LIU H, LI Z, ZHANG Y, et al. Antiviral effects of artemisinin and its derivatives[J]. Chinese medical journal, 2023, 136(24):2993-2995. doi: 10.1097/CM9.0000000000002934 pmid: 38018178
[38]	LIU Y J, ZHANG X H, LIU Z X, et al. Toosendanin suppresses African swine fever virus replication through upregulating interferon regulatory factor 1 in porcine alveolar macrophage cultures[J]. Frontiers in microbiology, 2022, 13:970501.